In prostate cancer patients receiving EBRT, when, if ever, do you use MRI to change your seminal vesicle coverage?  

For example, in standard high-risk we generally cover proximal 2cm to elective dose, before doing cone down boost to prostate and proximal 1cm.

If a tumor is localized away from the SV, would that affect your CTV?

If MRI shows SV invasion, how does that affect your CTV?



Answer from: Radiation Oncologist at Community Practice